Alembic gets USFDA nod for oncology injection Paclitaxel
Alembic Pharmaceuticals, an Indian maker of generic drugs, announced it had received USFDA's final approval for Paclitaxel injection multi-dose vials for use in.
Drugs
Pharma
Medical
USFDA approves Zydus Lifesciences anti-fungal injection
USFDA approves Zydus Lifesciences anti-fungal injection HQ Team October 26, 2022: Zydus Lifesciences announced that it had received final approval from the USFDA.
Drugs
Pharma
Aurobindo to recall two drugs with potential cancer risk
HQ Team October 26, 2022: Aurobindo Pharma US has initiated a voluntary recall of two lots of tablets in the American market due to the.
Pharma
Philips to slash 4,000 jobs as respirator recall slump sales
HQ team Koninklijke Philips N.V., an Amsterdam-based healthcare technology company, plans to slash 4,000 jobs after sales fell following a vast recall of.
Pharma
USFDA inspects Alembic’s pharma facility in Gujarat
HT Team October 18, 2022: The USFDA has inspected India’s Alembic Pharmaceuticals’ Oncology Injectable Formulation Facility at Panelav, Gujarat, according to a BSE.
Pharma
Lupin gets FDA approval for osteoarthritis medicine
September 22, 2022: Lupin Ltd., one of the top Indian pharmaceutical majors, has received approval from the US drug regulator United States Food.
Medical
Zydus Lifesciences Gets Tentative Approval for Sugammadex from USFDA
Zydus Lifesciences gets initial USFDA approval for Sugammadex